Coffee and Tea Consumption and the Risk of Parkinson's Disease
Identifieur interne : 001449 ( PascalFrancis/Corpus ); précédent : 001448; suivant : 001450Coffee and Tea Consumption and the Risk of Parkinson's Disease
Auteurs : GANG HU ; Siamak Bidel ; Pekka Jousilahti ; Riitta Antikainen ; Jaakko TuomilehtoSource :
- Movement disorders [ 0885-3185 ] ; 2007.
Descripteurs français
- Pascal (Inist)
English descriptors
Abstract
Several prospective studies have assessed the association between coffee consumption and Parkinson's disease (PD) risk, but the results are inconsistent. We examined the association of coffee and tea consumption with the risk of incident PD among 29,335 Finnish subjects aged 25 to 74 years without a history of PD at baseline. During a mean follow-up of 12.9 years, 102 men and 98 women developed an incident PD. The multivariate-adjusted (age, body mass index, systolic blood pressure, total cholesterol, education, leisure-time physical activity, smoking, alcohol and tea consumption, and history of diabetes) hazard ratios (HRs) of PD associated with the amount of coffee consumed daily (0, 1-4, and≥5 cups) were 1.00, 0.55, and 0.41 (P for trend = 0.063) in men, 1.00, 0.50, and 0.39 (P for trend = 0.073) in women, and 1.00, 0.53, and 0.40 (P for trend = 0.005) in men and women combined (adjusted also for sex), respectively. In both sexes combined, the multivariate-adjusted HRs of PD for subjects drinking ≥3 cups of tea daily compared with tea nondrinkers was 0.41 (95% CI 0.20-0.83). These results suggest that coffee drinking is associated with a lower risk of PD. More tea drinking is associated with a lower risk of PD.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
| pA |
|
|---|
Format Inist (serveur)
| NO : | PASCAL 08-0071412 INIST |
|---|---|
| ET : | Coffee and Tea Consumption and the Risk of Parkinson's Disease |
| AU : | GANG HU; BIDEL (Siamak); JOUSILAHTI (Pekka); ANTIKAINEN (Riitta); TUOMILEHTO (Jaakko) |
| AF : | Department of Health Promotion and Chronic Diseases Prevention, National Public Health Institute/Helsinki/Finlande (1 aut., 2 aut., 3 aut., 5 aut.); Department of Public Health, University of Helsinki/Helsinki/Finlande (1 aut., 2 aut., 5 aut.); Tampere School of Public Health, University of Tampere/Tampere/Finlande (3 aut.); Oulu City Hospital, Department of Public Health Science and General Practice, University of Oulu/Oulu/Finlande (4 aut.); South Ostrobothnia Central Hospital/Seinajoki/Finlande (5 aut.) |
| DT : | Publication en série; Niveau analytique |
| SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2007; Vol. 22; No. 15; Pp. 2242-2248; Bibl. 40 ref. |
| LA : | Anglais |
| EA : | Several prospective studies have assessed the association between coffee consumption and Parkinson's disease (PD) risk, but the results are inconsistent. We examined the association of coffee and tea consumption with the risk of incident PD among 29,335 Finnish subjects aged 25 to 74 years without a history of PD at baseline. During a mean follow-up of 12.9 years, 102 men and 98 women developed an incident PD. The multivariate-adjusted (age, body mass index, systolic blood pressure, total cholesterol, education, leisure-time physical activity, smoking, alcohol and tea consumption, and history of diabetes) hazard ratios (HRs) of PD associated with the amount of coffee consumed daily (0, 1-4, and≥5 cups) were 1.00, 0.55, and 0.41 (P for trend = 0.063) in men, 1.00, 0.50, and 0.39 (P for trend = 0.073) in women, and 1.00, 0.53, and 0.40 (P for trend = 0.005) in men and women combined (adjusted also for sex), respectively. In both sexes combined, the multivariate-adjusted HRs of PD for subjects drinking ≥3 cups of tea daily compared with tea nondrinkers was 0.41 (95% CI 0.20-0.83). These results suggest that coffee drinking is associated with a lower risk of PD. More tea drinking is associated with a lower risk of PD. |
| CC : | 002B17; 002B17G; 002B17A03 |
| FD : | Pathologie du système nerveux; Maladie de Parkinson; Facteur risque |
| FG : | Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central |
| ED : | Nervous system diseases; Parkinson disease; Risk factor |
| EG : | Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease |
| SD : | Sistema nervioso patología; Parkinson enfermedad; Factor riesgo |
| LO : | INIST-20953.354000162671070160 |
| ID : | 08-0071412 |
Links to Exploration step
Pascal:08-0071412Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Coffee and Tea Consumption and the Risk of Parkinson's Disease</title><author><name sortKey="Gang Hu" sort="Gang Hu" uniqKey="Gang Hu" last="Gang Hu">GANG HU</name><affiliation><inist:fA14 i1="01"><s1>Department of Health Promotion and Chronic Diseases Prevention, National Public Health Institute</s1><s2>Helsinki</s2><s3>FIN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="02"><s1>Department of Public Health, University of Helsinki</s1><s2>Helsinki</s2><s3>FIN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Bidel, Siamak" sort="Bidel, Siamak" uniqKey="Bidel S" first="Siamak" last="Bidel">Siamak Bidel</name><affiliation><inist:fA14 i1="01"><s1>Department of Health Promotion and Chronic Diseases Prevention, National Public Health Institute</s1><s2>Helsinki</s2><s3>FIN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="02"><s1>Department of Public Health, University of Helsinki</s1><s2>Helsinki</s2><s3>FIN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Jousilahti, Pekka" sort="Jousilahti, Pekka" uniqKey="Jousilahti P" first="Pekka" last="Jousilahti">Pekka Jousilahti</name><affiliation><inist:fA14 i1="01"><s1>Department of Health Promotion and Chronic Diseases Prevention, National Public Health Institute</s1><s2>Helsinki</s2><s3>FIN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="03"><s1>Tampere School of Public Health, University of Tampere</s1><s2>Tampere</s2><s3>FIN</s3><sZ>3 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Antikainen, Riitta" sort="Antikainen, Riitta" uniqKey="Antikainen R" first="Riitta" last="Antikainen">Riitta Antikainen</name><affiliation><inist:fA14 i1="04"><s1>Oulu City Hospital, Department of Public Health Science and General Practice, University of Oulu</s1><s2>Oulu</s2><s3>FIN</s3><sZ>4 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Tuomilehto, Jaakko" sort="Tuomilehto, Jaakko" uniqKey="Tuomilehto J" first="Jaakko" last="Tuomilehto">Jaakko Tuomilehto</name><affiliation><inist:fA14 i1="01"><s1>Department of Health Promotion and Chronic Diseases Prevention, National Public Health Institute</s1><s2>Helsinki</s2><s3>FIN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="02"><s1>Department of Public Health, University of Helsinki</s1><s2>Helsinki</s2><s3>FIN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="05"><s1>South Ostrobothnia Central Hospital</s1><s2>Seinajoki</s2><s3>FIN</s3><sZ>5 aut.</sZ></inist:fA14></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">08-0071412</idno><date when="2007">2007</date><idno type="stanalyst">PASCAL 08-0071412 INIST</idno><idno type="RBID">Pascal:08-0071412</idno><idno type="wicri:Area/PascalFrancis/Corpus">001449</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Coffee and Tea Consumption and the Risk of Parkinson's Disease</title><author><name sortKey="Gang Hu" sort="Gang Hu" uniqKey="Gang Hu" last="Gang Hu">GANG HU</name><affiliation><inist:fA14 i1="01"><s1>Department of Health Promotion and Chronic Diseases Prevention, National Public Health Institute</s1><s2>Helsinki</s2><s3>FIN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="02"><s1>Department of Public Health, University of Helsinki</s1><s2>Helsinki</s2><s3>FIN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Bidel, Siamak" sort="Bidel, Siamak" uniqKey="Bidel S" first="Siamak" last="Bidel">Siamak Bidel</name><affiliation><inist:fA14 i1="01"><s1>Department of Health Promotion and Chronic Diseases Prevention, National Public Health Institute</s1><s2>Helsinki</s2><s3>FIN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="02"><s1>Department of Public Health, University of Helsinki</s1><s2>Helsinki</s2><s3>FIN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Jousilahti, Pekka" sort="Jousilahti, Pekka" uniqKey="Jousilahti P" first="Pekka" last="Jousilahti">Pekka Jousilahti</name><affiliation><inist:fA14 i1="01"><s1>Department of Health Promotion and Chronic Diseases Prevention, National Public Health Institute</s1><s2>Helsinki</s2><s3>FIN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="03"><s1>Tampere School of Public Health, University of Tampere</s1><s2>Tampere</s2><s3>FIN</s3><sZ>3 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Antikainen, Riitta" sort="Antikainen, Riitta" uniqKey="Antikainen R" first="Riitta" last="Antikainen">Riitta Antikainen</name><affiliation><inist:fA14 i1="04"><s1>Oulu City Hospital, Department of Public Health Science and General Practice, University of Oulu</s1><s2>Oulu</s2><s3>FIN</s3><sZ>4 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Tuomilehto, Jaakko" sort="Tuomilehto, Jaakko" uniqKey="Tuomilehto J" first="Jaakko" last="Tuomilehto">Jaakko Tuomilehto</name><affiliation><inist:fA14 i1="01"><s1>Department of Health Promotion and Chronic Diseases Prevention, National Public Health Institute</s1><s2>Helsinki</s2><s3>FIN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="02"><s1>Department of Public Health, University of Helsinki</s1><s2>Helsinki</s2><s3>FIN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="05"><s1>South Ostrobothnia Central Hospital</s1><s2>Seinajoki</s2><s3>FIN</s3><sZ>5 aut.</sZ></inist:fA14></affiliation></author></analytic><series><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno><imprint><date when="2007">2007</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Nervous system diseases</term><term>Parkinson disease</term><term>Risk factor</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Pathologie du système nerveux</term><term>Maladie de Parkinson</term><term>Facteur risque</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Several prospective studies have assessed the association between coffee consumption and Parkinson's disease (PD) risk, but the results are inconsistent. We examined the association of coffee and tea consumption with the risk of incident PD among 29,335 Finnish subjects aged 25 to 74 years without a history of PD at baseline. During a mean follow-up of 12.9 years, 102 men and 98 women developed an incident PD. The multivariate-adjusted (age, body mass index, systolic blood pressure, total cholesterol, education, leisure-time physical activity, smoking, alcohol and tea consumption, and history of diabetes) hazard ratios (HRs) of PD associated with the amount of coffee consumed daily (0, 1-4, and≥5 cups) were 1.00, 0.55, and 0.41 (P for trend = 0.063) in men, 1.00, 0.50, and 0.39 (P for trend = 0.073) in women, and 1.00, 0.53, and 0.40 (P for trend = 0.005) in men and women combined (adjusted also for sex), respectively. In both sexes combined, the multivariate-adjusted HRs of PD for subjects drinking ≥3 cups of tea daily compared with tea nondrinkers was 0.41 (95% CI 0.20-0.83). These results suggest that coffee drinking is associated with a lower risk of PD. More tea drinking is associated with a lower risk of PD.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0></fA01><fA03 i2="1"><s0>Mov. disord.</s0></fA03><fA05><s2>22</s2></fA05><fA06><s2>15</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Coffee and Tea Consumption and the Risk of Parkinson's Disease</s1></fA08><fA11 i1="01" i2="1"><s1>GANG HU</s1></fA11><fA11 i1="02" i2="1"><s1>BIDEL (Siamak)</s1></fA11><fA11 i1="03" i2="1"><s1>JOUSILAHTI (Pekka)</s1></fA11><fA11 i1="04" i2="1"><s1>ANTIKAINEN (Riitta)</s1></fA11><fA11 i1="05" i2="1"><s1>TUOMILEHTO (Jaakko)</s1></fA11><fA14 i1="01"><s1>Department of Health Promotion and Chronic Diseases Prevention, National Public Health Institute</s1><s2>Helsinki</s2><s3>FIN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></fA14><fA14 i1="02"><s1>Department of Public Health, University of Helsinki</s1><s2>Helsinki</s2><s3>FIN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>5 aut.</sZ></fA14><fA14 i1="03"><s1>Tampere School of Public Health, University of Tampere</s1><s2>Tampere</s2><s3>FIN</s3><sZ>3 aut.</sZ></fA14><fA14 i1="04"><s1>Oulu City Hospital, Department of Public Health Science and General Practice, University of Oulu</s1><s2>Oulu</s2><s3>FIN</s3><sZ>4 aut.</sZ></fA14><fA14 i1="05"><s1>South Ostrobothnia Central Hospital</s1><s2>Seinajoki</s2><s3>FIN</s3><sZ>5 aut.</sZ></fA14><fA20><s1>2242-2248</s1></fA20><fA21><s1>2007</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>20953</s2><s5>354000162671070160</s5></fA43><fA44><s0>0000</s0><s1>© 2008 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>40 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>08-0071412</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Movement disorders</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC01 i1="01" l="ENG"><s0>Several prospective studies have assessed the association between coffee consumption and Parkinson's disease (PD) risk, but the results are inconsistent. We examined the association of coffee and tea consumption with the risk of incident PD among 29,335 Finnish subjects aged 25 to 74 years without a history of PD at baseline. During a mean follow-up of 12.9 years, 102 men and 98 women developed an incident PD. The multivariate-adjusted (age, body mass index, systolic blood pressure, total cholesterol, education, leisure-time physical activity, smoking, alcohol and tea consumption, and history of diabetes) hazard ratios (HRs) of PD associated with the amount of coffee consumed daily (0, 1-4, and≥5 cups) were 1.00, 0.55, and 0.41 (P for trend = 0.063) in men, 1.00, 0.50, and 0.39 (P for trend = 0.073) in women, and 1.00, 0.53, and 0.40 (P for trend = 0.005) in men and women combined (adjusted also for sex), respectively. In both sexes combined, the multivariate-adjusted HRs of PD for subjects drinking ≥3 cups of tea daily compared with tea nondrinkers was 0.41 (95% CI 0.20-0.83). These results suggest that coffee drinking is associated with a lower risk of PD. More tea drinking is associated with a lower risk of PD.</s0></fC01><fC02 i1="01" i2="X"><s0>002B17</s0></fC02><fC02 i1="02" i2="X"><s0>002B17G</s0></fC02><fC02 i1="03" i2="X"><s0>002B17A03</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Pathologie du système nerveux</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Maladie de Parkinson</s0><s2>NM</s2><s5>02</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Parkinson disease</s0><s2>NM</s2><s5>02</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Parkinson enfermedad</s0><s2>NM</s2><s5>02</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Facteur risque</s0><s5>09</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Risk factor</s0><s5>09</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Factor riesgo</s0><s5>09</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0><s5>37</s5></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0><s5>38</s5></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0><s5>39</s5></fC07><fC07 i1="04" i2="X" l="FRE"><s0>Pathologie du système nerveux central</s0><s5>40</s5></fC07><fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0><s5>40</s5></fC07><fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0><s5>40</s5></fC07><fN21><s1>035</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard><server><NO>PASCAL 08-0071412 INIST</NO><ET>Coffee and Tea Consumption and the Risk of Parkinson's Disease</ET><AU>GANG HU; BIDEL (Siamak); JOUSILAHTI (Pekka); ANTIKAINEN (Riitta); TUOMILEHTO (Jaakko)</AU><AF>Department of Health Promotion and Chronic Diseases Prevention, National Public Health Institute/Helsinki/Finlande (1 aut., 2 aut., 3 aut., 5 aut.); Department of Public Health, University of Helsinki/Helsinki/Finlande (1 aut., 2 aut., 5 aut.); Tampere School of Public Health, University of Tampere/Tampere/Finlande (3 aut.); Oulu City Hospital, Department of Public Health Science and General Practice, University of Oulu/Oulu/Finlande (4 aut.); South Ostrobothnia Central Hospital/Seinajoki/Finlande (5 aut.)</AF><DT>Publication en série; Niveau analytique</DT><SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2007; Vol. 22; No. 15; Pp. 2242-2248; Bibl. 40 ref.</SO><LA>Anglais</LA><EA>Several prospective studies have assessed the association between coffee consumption and Parkinson's disease (PD) risk, but the results are inconsistent. We examined the association of coffee and tea consumption with the risk of incident PD among 29,335 Finnish subjects aged 25 to 74 years without a history of PD at baseline. During a mean follow-up of 12.9 years, 102 men and 98 women developed an incident PD. The multivariate-adjusted (age, body mass index, systolic blood pressure, total cholesterol, education, leisure-time physical activity, smoking, alcohol and tea consumption, and history of diabetes) hazard ratios (HRs) of PD associated with the amount of coffee consumed daily (0, 1-4, and≥5 cups) were 1.00, 0.55, and 0.41 (P for trend = 0.063) in men, 1.00, 0.50, and 0.39 (P for trend = 0.073) in women, and 1.00, 0.53, and 0.40 (P for trend = 0.005) in men and women combined (adjusted also for sex), respectively. In both sexes combined, the multivariate-adjusted HRs of PD for subjects drinking ≥3 cups of tea daily compared with tea nondrinkers was 0.41 (95% CI 0.20-0.83). These results suggest that coffee drinking is associated with a lower risk of PD. More tea drinking is associated with a lower risk of PD.</EA><CC>002B17; 002B17G; 002B17A03</CC><FD>Pathologie du système nerveux; Maladie de Parkinson; Facteur risque</FD><FG>Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central</FG><ED>Nervous system diseases; Parkinson disease; Risk factor</ED><EG>Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease</EG><SD>Sistema nervioso patología; Parkinson enfermedad; Factor riesgo</SD><LO>INIST-20953.354000162671070160</LO><ID>08-0071412</ID></server></inist></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001449 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001449 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:08-0071412
|texte= Coffee and Tea Consumption and the Risk of Parkinson's Disease
}}
| This area was generated with Dilib version V0.6.23. |  |